A detailed history of Virtus ETF Advisers LLC transactions in Annexon, Inc. stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 15,339 shares of ANNX stock, worth $77,615. This represents 0.04% of its overall portfolio holdings.

Number of Shares
15,339
Previous 15,063 1.83%
Holding current value
$77,615
Previous $73,000 23.29%
% of portfolio
0.04%
Previous 0.04%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$4.49 - $7.2 $1,239 - $1,987
276 Added 1.83%
15,339 $90,000
Q2 2024

Aug 14, 2024

BUY
$4.33 - $6.79 $65,222 - $102,277
15,063 New
15,063 $73,000
Q2 2022

Aug 12, 2022

SELL
$2.11 - $4.06 $24,049 - $46,275
-11,398 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$2.73 - $11.94 $1,856 - $8,119
-680 Reduced 5.63%
11,398 $31,000
Q4 2021

Feb 14, 2022

BUY
$11.49 - $22.0 $34,872 - $66,770
3,035 Added 33.56%
12,078 $139,000
Q3 2021

Nov 15, 2021

SELL
$16.35 - $23.4 $7,717 - $11,044
-472 Reduced 4.96%
9,043 $168,000
Q2 2021

Aug 10, 2021

SELL
$17.81 - $27.48 $47,303 - $72,986
-2,656 Reduced 21.82%
9,515 $214,000
Q1 2021

May 17, 2021

BUY
$22.0 - $35.01 $4,686 - $7,457
213 Added 1.78%
12,171 $339,000
Q4 2020

Feb 12, 2021

BUY
$20.81 - $30.55 $248,845 - $365,316
11,958 New
11,958 $299,000

Others Institutions Holding ANNX

About Annexon, Inc.


  • Ticker ANNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 47,617,700
  • Market Cap $241M
  • Description
  • Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapeutics for autoimmune, neurodegenerative, and ophthalmic disorders. The company's C1q is an initiating molecule of the classical complement pathway that targets distinct disease processes, such as antibody-mediated autoimmune disease and complement-mediated n...
More about ANNX
Track This Portfolio

Track Virtus ETF Advisers LLC Portfolio

Follow Virtus ETF Advisers LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.